Table 1. Clinicopathological factors and BCL6 expression in 100 gastric cancers.
|
BCL6 expression
|
||||
|---|---|---|---|---|
| Factor | n | Positive (scorea) | Negative (scorea) | P-value |
| Gender | ||||
| Male | 67 | 17 (2.71±0.14) | 50 (0.00±0.00) | 0.646 |
| Female | 33 | 7 (2.43±0.29) | 26 (0.00±0.00) | |
| Histological type b | ||||
| Differentiated | 45 | 16 (2.82±0.10) | 29 (0.00±0.00) | 0.01 |
| Undifferentiated | 55 | 8 (2.25±0.31) | 47 (0.00±0.00) | |
| Depth of invasion | ||||
| T1-2 | 40 | 12 (2.58±0.19) | 28 (0.00±0.00) | 0.3 |
| T3-4 | 60 | 12 (2.67±0.18) | 48 (0.00±0.00) | |
| LN metastasis | ||||
| Absence | 25 | 6 (2.67±0.21) | 19 (0.00±0.00) | 1 |
| Presence | 75 | 18 (2.61±0.16) | 57 (0.00±0.00) | |
| Age (years) | ||||
| (mean±s.d.) | 65.6±10.7 | 65.2±12.0 | ||
n=number of cases; LN=lymph node.
a
The scores of each marker are average of ±standard error (s.e.).
b
Classified based on structure of elements. ‘Differentiated’ includes tubular and papillary types, whereas ‘undifferentiated’ consists of signet-ring and poorly differentiated types.